基于二维超声图像的机器学习预测透明细胞肾细胞癌Fuhrman分级
回顾性分析2013年3月至2023年7月病理确诊的235例透明细胞肾细胞癌患者超声图像与临床数据,其中67例为Fuhrman Ⅲ-Ⅳ级。基于超声图像提取影像组学特征构建临床、影像组学及联合模型,联合模型在训练集、内部验证集和外部验证集的AUC分别为0.871、0.785和0.826,高于临床和影像组学模型。
要点
- 联合模型在训练集、内部验证集、外部验证集AUC分别为0.871、0.785、0.826,高于临床和影像组学模型。
- 联合模型在阈值0-0.93范围内DCA显示具有临床实用性。
- 超声影像组学可客观预测透明细胞肾细胞癌Fuhrman分级,但临床指标仍不可或缺。
核心结论
- 应用超声影像组学技术可客观预测透明细胞肾细胞癌患者的Fuhrman分级,但某些临床指标仍不可或缺,强调临床实践中需整合使用。
研究设计与样本
- 回顾性分析2013年3月至2023年7月病理确诊的235例透明细胞肾细胞癌患者超声图像与临床数据,其中67例为Fuhrman Ⅲ-Ⅳ级;201例来自A医院,按8:2分为训练集161例和内部验证集40例,34例来自B医院作为外部验证集;使用ITK软件勾画超声图像,PyRadiomics软件提取影像组学特征,分别构建临床因素模型、影像组学特征模型及其联合模型。
诊断标准与关键数值
- 联合模型预测Fuhrman分级的AUC在训练集为0.871、内部验证集为0.785、外部验证集为0.826,均高于临床模型和影像组学模型;校准曲线显示联合模型预测概率与观察值一致性良好;DCA显示在阈值0-0.93范围内联合模型具有临床实用性。
临床应用与阅片要点
- 超声影像组学模型基于二维超声图像预测透明细胞肾细胞癌Fuhrman分级,联合模型纳入临床指标后预测性能优于单一临床或影像组学模型,作者强调临床指标仍不可或缺、需整合使用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Accurate assessment of Fuhrman grade is crucial for optimal clinical management and personalized treatment strategies in patients with clear cell renal cell carcinoma (CCRCC). In this study, we developed a predictive model using ultrasound (US) images to accurately predict the Fuhrman grade.
METHODS: Between March 2013 and July 2023, a retrospective analysis was conducted on the US imaging and clinical data of 235 patients with pathologically confirmed CCRCC, including 67 with Fuhrman grades Ⅲ and Ⅳ. This study included 201 patients from Hospital A who were divided into training set (n = 161) and an internal validation set (n = 40) in an 8:2 ratio. Additionally, 34 patients from Hospital B were included for external validation. US images were delineated using ITK software, and radiomics features were extracted using PyRadiomics software. Subsequently, separate models for clinical factors, radiomics features, and their combinations were constructed. The model's performance was assessed by calculating the area under the receiver operating characteristic curve (AUC), calibration curve and decision curve analysis (DCA).
RESULTS: In total, 235 patients diagnosed with CCRCC, comprising 168 low-grade and 67 high-grade tumors, were included in this study. A comparison of the predictive performances of different models revealed that the logistic regression model exhibited relatively good stability and robustness. The AUC of the combined model for the training, internal validation and external validation sets were 0.871, 0.785 and 0.826, respectively, which were higher than those of the clinical and imaging histology models. Furthermore, the calibration curve demonstrated excellent concordance between the predicted Fuhrman grade probability of CCRCC using the combined model and the observed values in both the training and validation sets. Additionally, within the threshold range of 0-0.93, the combined model demonstrated substantial clinical utility, as evidenced by DCA.
CONCLUSION: The application of US radiomics techniques enabled objective prediction of Fuhrman grading in patients with CCRCC. Nevertheless, certain clinical indicators remain indispensable, underscoring the pressing need for their integrated use in clinical practice.
ADVANCES IN KNOWLEDGE: Previous studies have predominantly focused on using computed tomography or magnetic resonance imaging modalities to predict the Fuhrman grade of CCRCC. Our findings demonstrate that a prediction model based on US images is more cost-effective, easily accessible and exhibits commendable performance. Consequently, this study offers a promising approach to maximizing the use of US examinations in future research.
引用
- Yang Y, Yuan Z, Ren Q, et al. Machine Learning-Enabled Fuhrman Grade in Clear-cell Renal Carcinoma Prediction Using Two-dimensional Ultrasound Images. Ultrasound Med Biol. 2024. PMID: 39317624. doi:10.1016/j.ultrasmedbio.2024.08.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。